Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.86)
# 635
Out of 5,132 analysts
454
Total ratings
41.6%
Success rate
12.69%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGNX REGENXBIO | Maintains: Buy | $34 → $32 | $7.99 | +300.50% | 15 | Feb 10, 2026 | |
| BLTE Belite Bio | Reiterates: Buy | $185 | $175.70 | +5.29% | 23 | Jan 28, 2026 | |
| NPCE NeuroPace | Maintains: Buy | $18 → $19 | $15.05 | +26.25% | 2 | Jan 27, 2026 | |
| SMTI Sanara MedTech | Reiterates: Buy | $36 | $18.91 | +90.38% | 7 | Jan 26, 2026 | |
| LPCN Lipocine | Maintains: Buy | $7 → $15 | $8.66 | +73.21% | 6 | Jan 21, 2026 | |
| VRAX Virax Biolabs Group | Reiterates: Buy | $3 → $1 | $0.21 | +384.03% | 2 | Jan 9, 2026 | |
| GLSI Greenwich LifeSciences | Maintains: Buy | $39 → $50 | $26.85 | +86.22% | 9 | Dec 30, 2025 | |
| BLFS BioLife Solutions | Reiterates: Buy | $32 | $22.23 | +43.95% | 5 | Dec 29, 2025 | |
| LEXX Lexaria Bioscience | Maintains: Buy | $4 → $1.5 | $0.62 | +140.96% | 8 | Dec 26, 2025 | |
| BEAT HeartBeam | Maintains: Buy | $2.5 → $5.5 | $1.33 | +313.53% | 2 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $21 | $8.88 | +136.49% | 30 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $39 | $33.24 | +17.33% | 3 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.10 | +536.36% | 3 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $7.21 | +24.83% | 21 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $9 | $2.78 | +223.74% | 11 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $1.5 | $0.23 | +561.67% | 4 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $1.52 | +360.53% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $0.63 | +535.93% | 14 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $69 | $47.69 | +44.68% | 7 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $42 | $28.49 | +47.42% | 17 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $89 | $51.95 | +71.32% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.02 | +390.20% | 2 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $17 | $17.03 | -0.18% | 20 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $2.5 | $0.57 | +338.60% | 23 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.41 | - | 24 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.75 | +300.00% | 14 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.82 | +148.23% | 20 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $3.81 | +162.47% | 5 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.09 | +378.47% | 17 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.18 | +238.98% | 7 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $2.02 | +345.54% | 2 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $3.86 | +107.25% | 20 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $12.94 | +77.74% | 23 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $10.97 | +45.85% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $19.63 | +27.36% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.23 | +143.90% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.29 | +1,210.04% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.80 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $2.02 | +24,652.48% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $12.95 | +270.66% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $104.51 | -81.82% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.66 | - | 2 | Apr 16, 2020 |
REGENXBIO
Feb 10, 2026
Maintains: Buy
Price Target: $34 → $32
Current: $7.99
Upside: +300.50%
Belite Bio
Jan 28, 2026
Reiterates: Buy
Price Target: $185
Current: $175.70
Upside: +5.29%
NeuroPace
Jan 27, 2026
Maintains: Buy
Price Target: $18 → $19
Current: $15.05
Upside: +26.25%
Sanara MedTech
Jan 26, 2026
Reiterates: Buy
Price Target: $36
Current: $18.91
Upside: +90.38%
Lipocine
Jan 21, 2026
Maintains: Buy
Price Target: $7 → $15
Current: $8.66
Upside: +73.21%
Virax Biolabs Group
Jan 9, 2026
Reiterates: Buy
Price Target: $3 → $1
Current: $0.21
Upside: +384.03%
Greenwich LifeSciences
Dec 30, 2025
Maintains: Buy
Price Target: $39 → $50
Current: $26.85
Upside: +86.22%
BioLife Solutions
Dec 29, 2025
Reiterates: Buy
Price Target: $32
Current: $22.23
Upside: +43.95%
Lexaria Bioscience
Dec 26, 2025
Maintains: Buy
Price Target: $4 → $1.5
Current: $0.62
Upside: +140.96%
HeartBeam
Dec 10, 2025
Maintains: Buy
Price Target: $2.5 → $5.5
Current: $1.33
Upside: +313.53%
Dec 8, 2025
Maintains: Buy
Price Target: $19 → $21
Current: $8.88
Upside: +136.49%
Dec 5, 2025
Maintains: Buy
Price Target: $26 → $39
Current: $33.24
Upside: +17.33%
Nov 24, 2025
Maintains: Buy
Price Target: $11 → $7
Current: $1.10
Upside: +536.36%
Nov 24, 2025
Reiterates: Buy
Price Target: $9
Current: $7.21
Upside: +24.83%
Nov 19, 2025
Maintains: Buy
Price Target: $13 → $9
Current: $2.78
Upside: +223.74%
Nov 17, 2025
Maintains: Buy
Price Target: $2.5 → $1.5
Current: $0.23
Upside: +561.67%
Nov 17, 2025
Initiates: Buy
Price Target: $7
Current: $1.52
Upside: +360.53%
Nov 17, 2025
Maintains: Buy
Price Target: $3 → $4
Current: $0.63
Upside: +535.93%
Nov 12, 2025
Maintains: Buy
Price Target: $64 → $69
Current: $47.69
Upside: +44.68%
Nov 11, 2025
Maintains: Buy
Price Target: $36 → $42
Current: $28.49
Upside: +47.42%
Nov 7, 2025
Maintains: Buy
Price Target: $98 → $89
Current: $51.95
Upside: +71.32%
Nov 3, 2025
Reiterates: Buy
Price Target: $5
Current: $1.02
Upside: +390.20%
Oct 31, 2025
Maintains: Buy
Price Target: $16 → $17
Current: $17.03
Upside: -0.18%
Oct 7, 2025
Maintains: Buy
Price Target: $2 → $2.5
Current: $0.57
Upside: +338.60%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.41
Upside: -
Sep 23, 2025
Reiterates: Buy
Price Target: $7
Current: $1.75
Upside: +300.00%
Sep 11, 2025
Reiterates: Buy
Price Target: $7
Current: $2.82
Upside: +148.23%
Sep 4, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $3.81
Upside: +162.47%
Sep 2, 2025
Reiterates: Buy
Price Target: $10
Current: $2.09
Upside: +378.47%
Sep 2, 2025
Reiterates: Buy
Price Target: $4
Current: $1.18
Upside: +238.98%
Sep 2, 2025
Reiterates: Buy
Price Target: $9
Current: $2.02
Upside: +345.54%
Aug 12, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $3.86
Upside: +107.25%
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $12.94
Upside: +77.74%
Jul 16, 2025
Reiterates: Buy
Price Target: $16
Current: $10.97
Upside: +45.85%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $19.63
Upside: +27.36%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.23
Upside: +143.90%
Jan 2, 2025
Reiterates: Buy
Price Target: $30
Current: $2.29
Upside: +1,210.04%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.80
Upside: -
May 17, 2024
Reiterates: Buy
Price Target: $500
Current: $2.02
Upside: +24,652.48%
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $12.95
Upside: +270.66%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $104.51
Upside: -81.82%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.66
Upside: -